Patent: (prefix with "WO" like WO6078908)
  1. WIPO
    Data
    Cmpds
    HGNC*
    WIPO Title
    Organization
    Deposition
    Downloads
  2. 10
    INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
    Mindset Pharma
    03/05/23
  3. 22
    MAP4K1 INHIBITORS
    Blueprint Medicines
    03/05/23
  4. 42
    SEROTONIN 5-HT2A, 5-HT2B, AND 5-HT2C RECEPTOR INVERSE AGONISTS
    Northeastern University
    03/05/23
  5. 25
    CDK7 SELECTIVE INHIBITORS AS ANTICANCER AGENTS
    JINGRUI BIOPHARMA CO., LTD.
    02/02/23
  6. 13
    M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES
    LYCIA THERAPEUTICS, INC.
    02/02/23
  7. 2
    NOVEL FATTY ACID MODIFIED UROCORTIN 2 DERIVATIVES AND THE USES THEREOF
    NOVO NORDISK A/S
    02/02/23
  8. 25
    TRICYCLIC COMPOUNDS
    Recurium Ip Holdings
    02/02/23
  9. 22
    COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES
    Novartis
    01/31/23
  10. 10
    CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME
    Baylor College Of Medicine
    01/31/23
  11. 25
    ETHER-LINKED ANTIVIRAL COMPOUNDS
    Pfizer
    01/31/23
  12. 30
    INHIBITORS TARGETING UBIQUITIN SPECIFIC PROTEASE 7 (USP7)
    Dana-Farber Cancer Institute
    01/31/23
  13. 46
    SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
    Sanofi
    12/30/22
  14. 19
    (AZA)BENZOTHIAZOLYL SUBSTITUTED PYRAZOLE COMPOUNDS
    Pfizer
    12/14/22
  15. 14
    AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY
    SHIONOGI & CO., LTD.
    12/14/22
  16. 25
    AROMATIC BRIDGED RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    F. Hoffmann-La Roche
    12/14/22
  17. 26
    AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    F. Hoffmann-La Roche
    12/14/22
  18. 24
    ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    F. Hoffmann-La Roche
    12/14/22
  19. 21
    INHIBITION OF TYK2 DEPENDENT SIGNALING PATHWAYS
    Janssen Pharmaceutica
    12/14/22
  20. 24
    ISOINDOLINONE COMPOUNDS
    MONTE ROSA THERAPEUTICS AG
    12/14/22
  21. 22
    MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Vertex Pharmaceuticals
    12/14/22
  22. 26
    MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS
    MERCK SHARP & DOHME LLC
    12/14/22
  23. 25
    MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
    MERCK SHARP & DOHME LLC
    12/14/22
  24. 33
    N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    F. Hoffmann-La Roche
    12/14/22
  25. 24
    SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
    F. Hoffmann-La Roche
    12/14/22
  26. 25
    TETRAHYDROISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF RED BLOOD DISORDERS AND INFLAMMATORY DISEASES
    Sanofi
    12/14/22
  27. 110
    3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS
    MERCK SHARP & DOHME LLC
    10/05/22
  28. 32
    POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS
    Gilead Sciences
    10/05/22
  29. 31
    SARS-COV-2 MPRO INHIBITOR COMPOUNDS
    Heptares Therapeutics
    10/05/22
  30. 49
    1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER
    Genentech
    08/07/22
  31. 42
    1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA
    Genentech
    08/07/22
  32. 56
    7-AZOLE SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    08/07/22
  33. 80
    CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS
    Boehringer Ingelheim International
    08/07/22
  34. 47
    DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    08/07/22
  35. 14
    N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
    Bayer Aktiengesellschaft
    08/07/22
  36. 34
    PYRAZOLE DERIVATIVES ASR ET KINASE INHIBITORS
    Eli Lilly
    08/07/22
  37. 125
    SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE
    Janssen Pharmaceutica
    08/07/22
  38. 384
    7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1
    MERCK SHARP & DOHME LLC
    07/22/22
  39. 61
    HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE
    Amgen
    07/21/22
  40. 226
    INTERLEUKIN-17 INHIBITORS
    Novartis
    07/21/22
  41. 236
    N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
    MERCK SHARP & DOHME LLC
    07/21/22
  42. 219
    SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS
    Boehringer Ingelheim International
    07/21/22
  43. 68
    SUBSTITUTED MORPHOLINE COMPOUNDS
    Genentech
    07/21/22
  44. 19
    ANTIVIRAL HETEROARYL KETONE DERIVATIVES
    Pfizer
    06/09/22
  45. 80
    NOVEL CORONAVIRUS MAIN PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Sichuan University
    06/09/22
  46. 29
    COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS
    Novartis
    05/24/22
  47. 71
    PHOSPHOLIPID COMPOUNDS AND USES THEREOF
    Gilead Sciences
    05/24/22
  48. 229
    SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
    The Broad Institute
    05/24/22
  49. 68
    SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
    The Broad Institute
    05/24/22
  50. 294
    TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
    Bristol-Myers Squibb
    05/24/22
  51. 83
    AMINOIMIDAZOLE FPR2 AGONISTS
    Bristol-Myers Squibb
    05/02/22
  52. 172
    CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS
    Janssen Pharmaceutica
    05/02/22
  53. 25
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Janssen Biotech
    05/02/22
  54. 6
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Janssen Biotech
    05/02/22
  55. 8
    DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Janssen Biotech
    05/02/22
  56. 141
    PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
    MERCK SHARP & DOHME CORP.
    05/02/22
  57. 168
    PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
    MERCK SHARP & DOHME CORP.
    05/02/22
  58. 100
    Aminocarbamoyl compounds for the treatment of viral infections
    F. Hoffmann-La Roche Ag
    03/30/22
  59. 178
    Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections
    Insilico Medicine Ip Limited
    01/27/22
  60. 44
    Compounds and method of treating covid-19
    Pfizer
    01/13/22
  61. 3
    Compounds and methods for the treatment of covid-19
    Pfizer
    01/13/22
  62. 94
    Nitrile-containing antiviral compounds
    Pfizer
    01/13/22
  63. 12
    Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
    Pfizer
    01/31/21
  64. 61
    Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
    Pfizer
    10/17/20
* for human-derived proteins